Old Web
English
Sign In
Acemap
>
authorDetail
>
Noelle Crompton
Noelle Crompton
Hoffmann-La Roche
Medicine
Immunology
Internal medicine
Obinutuzumab
Survival analysis
4
Papers
40
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
EFFICACY AND SAFETY OF IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS PREVIOUSLY TREATED WITH VENETOCLAX IN THE MURANO STUDY: PS1161
2019
Richard Greil
Graeme Fraser
Brian Leber
Reinhard Marks
Giulia Quaresmini
Moritz J. Middeke
Gianpietro Semenzato
W. Schary
Michelle Boyer
Madlaina Breuleux
Noelle Crompton
Kathryn Humphrey
Paula Marlton
Show All
Source
Cite
Save
Citations (3)
Efficacy and Safety of Ibrutinib (IBR) after Venetoclax (VEN) Treatment in IBR-Naïve Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Follow-up of Patients from the MURANO Study
2018
Blood
Richard Greil
Graeme Fraser
Brian Leber
Reinhard Marks
Giulia Quaresmini
Jan Moritz Middeke
Gianpietro Semenzato
William Schary
Michelle Boyer
Madlaina Breuleux
Noelle Crompton
Kathryn Humphrey
Paula Marlton
Show All
Source
Cite
Save
Citations (8)
Progression By Lymphocytosis Correlates with Favourable Long-Term Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL)
2016
Blood
Alexandra Bazeos
Craig Gower
Francine Swann
Peter Trask
Mark Dixon
Noelle Crompton
Nelson Kinnersley
Othman Al-Sawaf
Valentin Goede
Günter Fingerle-Rowson
Kathryn Humphrey
Show All
Source
Cite
Save
Citations (0)
Updated survival analysis from the CLL11 study: Obinutuzumab versus rituximab in chemoimmunotherapy-treated patients with chronic lymphocytic leukemia
2015
Blood
Valentin Goede
Kirsten Fischer
Francesc Bosch
George A. Follows
Henrik Frederiksen
Antonio Cuneo
Heinz Ludwig
Noelle Crompton
Joerg Maurer
Marianne Uguen
Günter Fingerle-Rowson
Michael Hallek
Show All
Source
Cite
Save
Citations (29)
1